middle.news
Nuix Accelerates ACV Growth Amid Longer Sales Cycles in 1H25
7:03pm on Monday 2nd of June, 2025 AEST
•
Software
Read Story
Nuix Accelerates ACV Growth Amid Longer Sales Cycles in 1H25
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Annualised Contract Value expected to rise 8-9% to $215-$217 million
Statutory Revenue forecasted between $104-$106 million, up 6-8%
Underlying EBITDA slightly down 1-8%, Cash EBITDA up 7-26%
Nuix Neo ACV surges 360% to approximately $19 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nuix (ASX:NXL)
OPEN ARTICLE